Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Myasthenia Gravis × Prednisolone × Clear all

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myasthenia Gravis 1 Metastatic Castration-resistant Prostate Cancer 1 Adrenal Insufficiency 1 Abiraterone Acetate 1

Interventions

telitacicept 3 rozanolixizumab 2 Prednisone 2 ravulizumab 1 fludarabine 1 blinatumomab 1 Pyridostigmine Bromide 1 Psychodrama 1 Prednisolone 1 Population Groups 1 Cyclophosphamide 1 Art Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡